Professor | Liping Xie | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Liping Xie
Contact Information	lipingxie@njmu.edu.cn
Language ability	Chinese, English
Province	Jiangsu

Upload Avatar (500 x 500)

Name

Liping Xie

Contact Information

lipingxie@njmu.edu.cn

Language ability

Chinese, English

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing Medical University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2001-09 to 2006-06: Clinical Medicine, Inner Mongolia University of Science and Technology, Baotou Medical College 2006-09 to 2011-06: Pathology and Pathophysiology, Nanjing Medical University National Natural Science Foundation Outstanding Youth Fund recipient Jiangsu Province Higher Education 'Qinglan Project' Young and Middle-aged Academic Leader
Work Experience	2011-08 to 2016-08: Lecturer, School of Basic Medicine, Nanjing Medical University 2019-08 to 2020-08: Visiting Scholar, School of Biomedical Sciences, The Chinese University of Hong Kong 2016-09 to 2021-10: Associate Professor, School of Basic Medicine, Nanjing Medical University 2021-11 to Present: Professor, Department of Pathology and Pathophysiology, School of Basic Medicine, Nanjing Medical University
Awards	2021: Jiangsu Province Higher Education 'Qinglan Project' Young and Middle-aged Academic Leader 2021: Jiangsu Province Science and Technology First Prize (Rank 3) 2019: Chinese Medical Science and Technology Second Prize (Rank 4) 2016: Ministry of Education Higher Education Scientific Research Outstanding Achievement Award First Prize (Rank 3) 2016: Jiangsu Province Science and Technology First Prize (Rank 3) 2014: Chinese Medical Science and Technology Second Prize (Rank 8) 2021: Silver Award at the 7th National Undergraduate Basic Medicine Innovation Research and Experimental Design Forum (Mentor) 2016: First Prize at the 4th National Undergraduate Basic Medicine Innovation Forum and Experimental Design Competition (Mentor) 2019: Qianjiang Elite Award

University/Lab Affiliation and Title

Nanjing Medical University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2001-09 to 2006-06: Clinical Medicine, Inner Mongolia University of Science and Technology, Baotou Medical College
2006-09 to 2011-06: Pathology and Pathophysiology, Nanjing Medical University
National Natural Science Foundation Outstanding Youth Fund recipient
Jiangsu Province Higher Education 'Qinglan Project' Young and Middle-aged Academic Leader

Work Experience

2011-08 to 2016-08: Lecturer, School of Basic Medicine, Nanjing Medical University
2019-08 to 2020-08: Visiting Scholar, School of Biomedical Sciences, The Chinese University of Hong Kong
2016-09 to 2021-10: Associate Professor, School of Basic Medicine, Nanjing Medical University
2021-11 to Present: Professor, Department of Pathology and Pathophysiology, School of Basic Medicine, Nanjing Medical University

Awards

2021: Jiangsu Province Higher Education 'Qinglan Project' Young and Middle-aged Academic Leader
2021: Jiangsu Province Science and Technology First Prize (Rank 3)
2019: Chinese Medical Science and Technology Second Prize (Rank 4)
2016: Ministry of Education Higher Education Scientific Research Outstanding Achievement Award First Prize (Rank 3)
2016: Jiangsu Province Science and Technology First Prize (Rank 3)
2014: Chinese Medical Science and Technology Second Prize (Rank 8)
2021: Silver Award at the 7th National Undergraduate Basic Medicine Innovation Research and Experimental Design Forum (Mentor)
2016: First Prize at the 4th National Undergraduate Basic Medicine Innovation Forum and Experimental Design Competition (Mentor)
2019: Qianjiang Elite Award

Areas of Focus	Molecular mechanisms and drug prevention and treatment of cardiovascular diseases
Publications	S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3beta signaling., Zhao S, Song TY, Wang ZY, Gao J, Cao JW, Hu LL, Huang ZR, Xie LP, Ji Y., 2022 S-nitrosylation-mediated coupling of G-protein alpha-2 with CXCR5 induces Hippo/YAP-dependent diabetes-accelerated atherosclerosis., Chao ML, Luo S, Zhang C, Zhou X, Zhou M, Wang J, Kong C, Chen J, Lin Z, Tang X, Sun S, Tang X, Chen H, Wang H, Wang D, Sun JP, Han Y, Xie L, Ji Y., 2021 Inhibition of HSP90 S-nitrosylation Alleviates Cardiac Fibrosis via TGFbeta/SMAD3 Signaling Pathway., Zhang X, Zhang Y, Miao Q, Shi Z, Hu L, Liu S, Gao J, Zhao S, Chen H, Huang Z, Han Y, Ji Y, Xie L., 2021 HINT1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing HOXA5 (Homeobox A5) Expression., Zhang Y, Da Q, Cao S, Yan K, Shi Z, Miao Q, Li C, Hu L, Sun S, Wu W, Wu L, Chen F, Wang L, Gao Y, Huang Z, Shao Y, Chen H, Wei Y, Chen F, Han Y,Xie L, Ji Y., 2021 Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway., Zhao S, Song T, Gu Y, Zhang Y, Cao S, Miao Q, Zhang X, Chen H, Gao Y, Zhang L, Han Y, Wang H, Pu J, Xie L, Ji Y., 2021 SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation., Tang X#, Pan L, Zhao S, Dai F, Chao M, Jiang H, Li X, Lin Z, Huang Z, Meng G, Wang C, Chen C, Liu J, Wang X, Ferro A, Wang H, Chen H, Gao Y, Lu Q, Xie L, Han Y, Ji Y., 2020 Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation., Xie L, Gu Y, Wen M, Zhao S, Wang W, Ma Y, Meng G, Han Y, Wang Y, Liu G, Moore PK, Wang X, Wang H, Zhang Z, Yu Y, Ferro A, Huang Z,Ji Y., 2016 SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells., Xie L, Feng H, Li S, Meng G, Liu S, Tang X, Ma Y, Han Y, Xiao Y, Gu Y, Shao Y, Park CM, Xian M, Huang Y, Ferro A, Wang R, Moore PK, Wang H, Ji Y., 2016

Areas of Focus

Molecular mechanisms and drug prevention and treatment of cardiovascular diseases

Publications

S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3beta signaling., Zhao S, Song TY, Wang ZY, Gao J, Cao JW, Hu LL, Huang ZR*, Xie LP*, Ji Y*., 2022
S-nitrosylation-mediated coupling of G-protein alpha-2 with CXCR5 induces Hippo/YAP-dependent diabetes-accelerated atherosclerosis., Chao ML, Luo S, Zhang C, Zhou X, Zhou M, Wang J, Kong C, Chen J, Lin Z, Tang X, Sun S, Tang X, Chen H, Wang H, Wang D, Sun JP, Han Y*, Xie L*, Ji Y*., 2021
Inhibition of HSP90 S-nitrosylation Alleviates Cardiac Fibrosis via TGFbeta/SMAD3 Signaling Pathway., Zhang X, Zhang Y, Miao Q, Shi Z, Hu L, Liu S, Gao J, Zhao S, Chen H, Huang Z, Han Y, Ji Y*, Xie L*., 2021
HINT1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing HOXA5 (Homeobox A5) Expression., Zhang Y, Da Q, Cao S, Yan K, Shi Z, Miao Q, Li C, Hu L, Sun S, Wu W, Wu L, Chen F, Wang L, Gao Y, Huang Z, Shao Y, Chen H, Wei Y, Chen F, Han Y*,Xie L*, Ji Y*., 2021
Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway., Zhao S, Song T, Gu Y, Zhang Y, Cao S, Miao Q, Zhang X, Chen H, Gao Y, Zhang L, Han Y, Wang H, Pu J, Xie L*, Ji Y*., 2021
SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation., Tang X#, Pan L, Zhao S, Dai F, Chao M, Jiang H, Li X, Lin Z, Huang Z, Meng G, Wang C, Chen C, Liu J, Wang X, Ferro A, Wang H, Chen H, Gao Y, Lu Q, Xie L*, Han Y*, Ji Y*., 2020
Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation., Xie L, Gu Y, Wen M, Zhao S, Wang W, Ma Y, Meng G, Han Y, Wang Y, Liu G, Moore PK, Wang X, Wang H, Zhang Z, Yu Y, Ferro A, Huang Z*,Ji Y*., 2016
SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells., Xie L, Feng H, Li S, Meng G, Liu S, Tang X, Ma Y, Han Y, Xiao Y, Gu Y, Shao Y, Park CM, Xian M, Huang Y, Ferro A, Wang R, Moore PK, Wang H*, Ji Y*., 2016

Cardiovascular Molecular Mechanisms Drug Prevention Treatment Heart Disease Pathophysiology Research Medicine Biochemistry Pharmacology

Er Dan Dong - Peking University

Wei Zhen Zhang - Peking University

Kong Wei - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us